mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
-0.086 |
0.05 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.05 |
mRNA |
AZ-3146 |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.05 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.06 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.06 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.06 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.06 |
mRNA |
EHT 1864 |
GDSC1000 |
pan-cancer |
AAC |
0.067 |
0.06 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.06 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.06 |